Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04603417 · ClinicalTrials.gov registry record · NA

Pain Avoidance Behavior and Its Relation to Risk for Opioid Use in Chronic Pain Patients

A NA study, sponsored by The Cleveland Clinic.

Completed
Registry status
NA
Development phase
63
Enrollment target

NCT04603417 is a NA study that has completed, run by The Cleveland Clinic. The registered enrollment target is 63 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04603417, a NA study, has completed, sponsored by The Cleveland Clinic.

COMPLETED
Registry status
NA
Development phase
63 participants
Enrollment target

Study Summary

This study is designed to find behavioral and neurophysiological correlates of pain avoidance behavior among chronic pain patients, controlling for risk for opioid use disorder. Further, traits and risk factors that contribute to pain avoidance behavior will be investigated. The knowledge gained will broaden the current understanding of mechanisms involved in pain avoidance behavior in chronic pain patients, and help devise novel interventions.

Interventions

  • DIAGNOSTIC_TEST Electroencephalography (EEG)/Magnetoencephalography (MEG)/MRI

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2020-08-15
Est. Completion 2024-04-30
Phase NA

Sponsor

The Cleveland Clinic

688 total trials

What the Registry Record Tells You About NCT04603417

The ClinicalTrials.gov registry entry for NCT04603417 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cleveland Clinic, which has 688 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Electroencephalography (EEG)/Magnetoencephalography (MEG)/MRI is the first listed.

NCT04603417 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT04603417 about?

NCT04603417 is a clinical study titled "Pain Avoidance Behavior and Its Relation to Risk for Opioid Use in Chronic Pain Patients". This study is designed to find behavioral and neurophysiological correlates of pain avoidance behavior among chronic pain patients, controlling for risk for opioid use disorder. Further, traits and risk factors that contribute to pain avoidance behavior will be investigated. The knowledge gained wil...

What is the current status of trial NCT04603417?

This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2020-08-15. Estimated completion is 2024-04-30.

What interventions are being tested in trial NCT04603417?

The interventions under investigation include: Electroencephalography (EEG)/Magnetoencephalography (MEG)/MRI (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04603417?

This trial is sponsored by The Cleveland Clinic, which has 688 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.